Chiesi Nordic
Eleni Kopsida, Ph.D. currently serves as the Value and Access Manager at Chiesi Nordic, a position held since February 2022. Previously, Eleni Kopsida worked at Parexel as a Senior Consultant and Manager and as a Consultant focusing on Health Economics and Market Access from April 2020 to February 2022. Experience at IQVIA included project management and real-world evidence studies from February 2016 to April 2020. As a co-founder and Secretary of Vetenskap i Samhället, responsibilities encompassed strategy development and project management from February 2015 to March 2017. Eleni Kopsida served on the Executive Board of the KI Postdoc Association, contributing to event coordination and networking from December 2013 to February 2016. Research experience includes a postdoctoral role at Karolinska Institutet and a PhD in Behavioral Genetics/Neuroscience from Cardiff University, where other educational qualifications include an MSc in Neuropsychology and a BSc in Psychology.
Chiesi Nordic
1 followers
Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 5000 people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.